Latest From Biotech Now

Reimbursement Considerations for Early Stage Companies


Panelists at Tuesday’s breakout session – Reimbursement Considerations for Early Stage Companies – overwhelmingly agreed that emerging biotech companies must consider reimbursement at the earliest stages of development. Christopher de Wolff, MSFS, Consultant, Numerof & Associates, Inc. moderated the panel and kicked it off by pointing out that many drugs achieve regulatory approval yet fail when they reach the market because of a lack of data and evidence directed at reimbursement. He asserted that the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Integrate and Collaborate to Drive Advancements in Oncology Treatments

A New Paradigm in Oncology Treatment

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, from improvements in screening to the development of more personalized, treatments. In a 2014 BIO International Convention Super Session on Tuesday moderated by BioCentury Editor Susan Schaeffer, panelists discussed the pressing need for companies to increase collaboration with each other and with industry stakeholders, including patient advocacy groups and academic medical centers, to speed the development and delivery of new Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Turning the Tide on STEM Education


According to the US Department of Education, only 16 percent of American high school seniors are proficient in mathematics and interested in a career in a Science, Technology, Engineering or Math (STEM) field. Even among students who do major in a STEM field, only about half go on to work in a related career. As an industry, we have a responsibility to not only prepare today’s students for careers in STEM fields but also to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Syringes for Clinical Trials


Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they require innovative approaches to manage drug development, particularly early development work. Any competitive advantage in the development process is highly prized – and one approach is to begin the development of the compound in a prefilled syringe earlier in the process, rather than later. Traditionally, biopharmaceutical companies have almost exclusively used vials in drug development. There are good reasons for Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Transforming Healthcare through Digital Innovation


Imagine being connected to expert health coaches on a daily basis instead of only at your annual doctor’s visit. What would it be like to be told on a real-time, continuous basis how many minutes of exercise at a specific heart rate was required, foods you needed to eat, and behaviors you needed to avoid in order to be feel better and be healthier? What if this information meant you could get off your hypertensive medications Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,